Abstract
Iodinated contrast media (CM) are widely used in radiological procedures, and carry a risk of adverse reactions with possible sequelae or death. Various and numerous reactions have been reported, most of which are transient ones and do not threaten the patients life. Immediate adverse reactions include adverse effects directly related to the osmotic load or to the CM chemotoxicity, and immediate hypersensitivity reactions. The exact incidence of the different types of reactions is difficult to establish because not all cases are reported and because a unique severity scale is lacking. All the underlying mechanisms have not been evidenced yet, as patients are rarely properly investigated. Allergic immediate hypersensitivity probably provokes the most severe reactions, whereas non-allergic hypersensitivity determines moderate reactions. Diagnostic tools are available and consist in tryptase and histamine measurements and in skin testing. Late reactions include skin or systemic reactions due to T-lymphocytes-mediated delayed hypersensitivity, nephropathy and dysthyroidism. Delayed allergic hypersentivity can be diagnosed by skin testing with delayed reading. Allergic hypersensitivity, immediate or delayed, means immune mechanisms and is a contraindication of further administration of the culprit CM.
Keywords: Contrast Media, adverse effects, Histamine Release, Hypersensitivity, Delayed, Immediate, Kidney Failure
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Immediate and Late Adverse Reactions to Iodinated Contrast Media: A Pharmacological Point of View
Volume: 5 Issue: 2
Author(s): Pascale Dewachter, Dominique Laroche, Claudie Mouton-Faivre and Olivier Clement
Affiliation:
Keywords: Contrast Media, adverse effects, Histamine Release, Hypersensitivity, Delayed, Immediate, Kidney Failure
Abstract: Iodinated contrast media (CM) are widely used in radiological procedures, and carry a risk of adverse reactions with possible sequelae or death. Various and numerous reactions have been reported, most of which are transient ones and do not threaten the patients life. Immediate adverse reactions include adverse effects directly related to the osmotic load or to the CM chemotoxicity, and immediate hypersensitivity reactions. The exact incidence of the different types of reactions is difficult to establish because not all cases are reported and because a unique severity scale is lacking. All the underlying mechanisms have not been evidenced yet, as patients are rarely properly investigated. Allergic immediate hypersensitivity probably provokes the most severe reactions, whereas non-allergic hypersensitivity determines moderate reactions. Diagnostic tools are available and consist in tryptase and histamine measurements and in skin testing. Late reactions include skin or systemic reactions due to T-lymphocytes-mediated delayed hypersensitivity, nephropathy and dysthyroidism. Delayed allergic hypersentivity can be diagnosed by skin testing with delayed reading. Allergic hypersensitivity, immediate or delayed, means immune mechanisms and is a contraindication of further administration of the culprit CM.
Export Options
About this article
Cite this article as:
Dewachter Pascale, Laroche Dominique, Mouton-Faivre Claudie and Clement Olivier, Immediate and Late Adverse Reactions to Iodinated Contrast Media: A Pharmacological Point of View, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2006; 5 (2) . https://dx.doi.org/10.2174/187152306776872406
DOI https://dx.doi.org/10.2174/187152306776872406 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Aberrant Lipid Metabolism of Cancer Stem Cells in Cancer Progression
Current Cancer Drug Targets Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials
Current Angiogenesis (Discontinued) Role of Endothelin in Uteroplacental Circulation and Fetal Vascular Function
Current Vascular Pharmacology Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom Communities Associated with GHB and Precursors
Current Drug Metabolism Vascular Disease: A New Progenitor Biology
Current Vascular Pharmacology Snake Venom Proteins and Peptides as Novel Antibiotics Against Microbial Infections
Current Proteomics Ventilatory Abnormalities During Exercise in Heart Failure: A Mini Review
Current Respiratory Medicine Reviews Kidney in Diabetes: from Organ Damage Target to Therapeutic Target
Current Drug Metabolism Stroke as a Consequence of Sleep Apnea: Epidemiology, Pathophysiology and Treatment Strategies
Current Respiratory Medicine Reviews Acyl Thiourea Derivatives Containing Pyrazole Ring Selective Targeting of Human Aurora Kinases in Breast and Bone Cancer
Letters in Drug Design & Discovery Why Not to Use the Handgrip Test in the Assessment of Cardiovascular Autonomic Neuropathy Among Patients with Diabetes Mellitus?
Current Vascular Pharmacology Glucose Transport and Metabolism in Sertoli Cell: Relevance for Male Fertility
Current Chemical Biology PDE-5 Inhibitors: Clinical Points
Current Drug Targets Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage
Current Drug Targets Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets Effects and Perspectives of Chinese Patent Medicines for Tonifying <i>Qi</i> and Promoting Blood Circulation on Patients with Cerebral Infarction
Current Vascular Pharmacology Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines by Promoting Blood Circulation and Removing Blood Stasis: Experience from Combination Therapy in Chinese Medicine
Current Vascular Pharmacology Blockade of Renin Angiotensin System in Heart Failure Post-Myocardial Infarction: What is the Best Therapy?
Recent Patents on Cardiovascular Drug Discovery Anti-Proliferative Compounds for the Prevention of Restenosis: Anti-Restenotic Mechanisms of Paclitaxel Action
Current Pharmaceutical Design Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design